Albert D. Dyrness

CIK 1664801 · last filed 2026-02-11

Albert D. Dyrness is a corporate insider who has filed 13 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for PURR, was dated Feb 11, 2026. Across all open-market trades the lifetime net is +$20.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $362.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$362.5K

Companies

3

Total Filings

13

Lifetime Open-Market Net

$20.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PURR Director 41,671 $8.70 $362.5K $0 2 2026-02-11
Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Director 0 $1.26 $0 $20.5K 9 2025-12-03
Outlook Therapeutics, Inc. (ONSIZ) Delisted Director $0 2 2017-10-30

Recent Filings

13 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2026-02-11 PURR Grant (A) +40,789 $0 EDGAR
2025-12-23 PURR Other (J) +882 $0 EDGAR
2025-12-03 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Disp (D) −4,537 $0 EDGAR
2025-07-15 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +4,000 $0 EDGAR
2024-12-05 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +373 $0 EDGAR
2023-05-31 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Buy (P) +23,255 $10.9K EDGAR
2022-12-22 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +3,770 $0 EDGAR
2022-04-08 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +14,152 $0 EDGAR
2020-07-02 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Grant (A) +8,005 $0 EDGAR
2020-06-12 Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted Buy (P) +2,409 $9.7K EDGAR
Showing 110 of 13
Page 1 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.